Inactive Instrument

News Curative Biotechnology, Inc. Other OTC

Equities

Curative Biotechnology, Inc. Names Cary Sucoff to Board of Directors	22-05-12	PR
Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration	22-05-03	PR
Curative Biotechnology Announces Cooperative Research and Development Agreement(CRADA) with the National Eye Institute (NEI) for Clinical Evaluation of its Proprietary Ocular Metformin Formulation in Age-Related Macular Degeneration	22-03-21	PR
Curative Biotechnology : Announces IMT504 License For Development Of Proprietary Next-Gen COVID-19 Vaccine	21-10-07	PR
Curative Biotechnology : Appoints Marc Drimer, CPA to Board of Directors as Independent Director and Chairman of Audit Committee	21-07-15	AQ
Curative Biotechnology, Inc. Appoints Marc Drimer to Board of Directors as Independent Director and Chairman of Audit Committee	21-07-15	CI
Choroideremia Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight \| 4D Molecular Therapeutics, Roche, Biogen and Many Others	21-06-08	AQ
Curative Biotechnology, Inc. Files 2021 First Quarter Financials and Issues Letter to Shareholders	21-05-25	GL

No results for this search